+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Regression of macular edema secondary to branch retinal vein occlusion during anti-TNF-alpha therapy for rheumatoid arthritis



Regression of macular edema secondary to branch retinal vein occlusion during anti-TNF-alpha therapy for rheumatoid arthritis



Clinical Ophthalmology 4: 667-670



A patient with macular edema secondary to a branch retinal vein occlusion (BRVO) was treated with intravenous injections of infliximab, an antitumor necrosis factor (TNF)-alpha antibody, for her rheumatoid arthritis (RA). Before the injection, the thickness of the right fovea, determined by optical coherent tomography, was 629 mum and the best-corrected visual acuity (BCVA) was 20/50. After eight injections of infliximab and 10 months after the first injection, her foveal thickness was decreased to 293 mum and the visual acuity improved to 20/20. There was no recurrence of macular edema during the infliximab injections. However, the infliximab injection was stopped because the patient developed pneumonia. Eight months after stopping the infliximab injection, her foveal thickness increased to 494 mum. To treat the RA, her orthopedists began weekly subcutaneous injections of etanercept, a fusion protein of a section of the TNF receptor and immunoglobulin. Five months later, the foveal thickness had decreased to 260 mum, and the visual acuity remained at 20/25(+). Because TNF-alpha is known to break down the blood-retinal barrier, the improvements in our case suggest that TNF-alpha plays a role in the pathogenesis of macular edema in some patients with BRVO.

(PDF emailed within 1 workday: $29.90)

Accession: 055446939

Download citation: RISBibTeXText

PMID: 20689780


Related references

Rebound of macular edema after intravitreal bevacizumab therapy in eyes with macular edema secondary to branch retinal vein occlusion. Retina 31(6): 1075-1082, 2011

Intravitreal injection of bevacizumab for macular edema secondary to branch retinal vein occlusion:results after 12 months and multiple regression analysis. Retina 29(9): 1242-1248, 2010

Combination therapy with intravitreal bevacizumab and macular grid and scatter laser photocoagulation in patients with macular edema secondary to branch retinal vein occlusion. Journal of Ocular Pharmacology and Therapeutics 31(3): 179-185, 2016

One-year results after intravitreal bevacizumab therapy for macular edema secondary to branch retinal vein occlusion. Graefe's Archive for Clinical and Experimental Ophthalmology 247(1): 27-33, 2008

Efficacy of single bevacizumab injection as adjuvant therapy to laser photocoagulation in macular edema secondary to branch retinal vein occlusion. Clinical Ophthalmology 10(): 2135-2140, 2016

Effect of vitreomacular adhesion on antivascular endothelial growth factor therapy for macular edema secondary to branch retinal vein occlusion. Japanese Journal of Ophthalmology 58(2): 139-145, 2014

Combination Therapy Of Intravitreal Ranibizumab And Subthreshold Micropulse Photocoagulation For Macular Edema Secondary To Branch Retinal Vein Occlusion: 6-Month Result. Retina: -, 2018

Prolongation of injection interval after switching therapy from ranibizumab to aflibercept in Japanese patients with macular edema secondary to branch retinal vein occlusion. Clinical Ophthalmology 11: 403-408, 2017

Treatment of macular edema secondary to branch retinal vein occlusion. Rinsho Ganka 59(5): 745-748, 2005

Retinal thickness and foveal threshold in macular edema secondary to branch retinal vein occlusion. Rinsho Ganka 53(3): 307-310, March, 1999

Serous retinal detachment in patients with macular edema secondary to branch retinal vein occlusion. Arquivos Brasileiros de Oftalmologia 79(1): 9-11, 2016

Intravitreal bevacizumab alone or combined with macular laser photocoagulation for recurrent or persistent macular edema secondary to branch retinal vein occlusion. Journal of Ophthalmology 2014: 173084-173084, 2014

Changes in Retinal Microcirculation After Intravitreal Ranibizumab Injection in Eyes With Macular Edema Secondary to Branch Retinal Vein Occlusion. Investigative Ophthalmology & Visual Science 58(2): 1246-1255, 2017

Pegaptanib sodium for macular edema secondary to branch retinal vein occlusion. American Journal of Ophthalmology 149(1): 147-154, 2010

Intravitreal bevacizumab for macular edema secondary to branch retinal vein occlusion. Retina 31(9): 1856-1862, 2012